AM630, a competitive cannabinoid receptor antagonist
- 5 May 1995
- journal article
- Published by Elsevier in Life Sciences
- Vol. 56 (23-24), 1949-1955
- https://doi.org/10.1016/0024-3205(95)00175-6
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparationsEuropean Journal of Pharmacology, 1995
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorFEBS Letters, 1994
- (R)-Methanandamide: A Chiral Novel Anandamide Possessing Higher Potency and Metabolic StabilityJournal of Medicinal Chemistry, 1994
- Cross‐tolerance between delta‐9‐tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212‐2 and anandamideBritish Journal of Pharmacology, 1993
- The evidence for the existence of cannabinoid receptorsGeneral Pharmacology: The Vascular System, 1993
- Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea‐pig small intestineBritish Journal of Pharmacology, 1992
- pA2 and receptor differentiation: A statistical analysis of competitive antagonismLife Sciences, 1979